Total Payments
$2,704
2024 Payments
$322.99
Companies
16
Transactions
60
Medicare Patients
10,741
Medicare Billing
$4.6M
Payment Breakdown by Category
Food & Beverage$2,704 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,704 | 60 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $537.89 | 8 | $0 (2021) |
| Allergan, Inc. | $393.67 | 9 | $0 (2021) |
| ABBVIE INC. | $354.16 | 14 | $0 (2024) |
| Alcon Vision LLC | $254.67 | 3 | $0 (2022) |
| Genentech USA, Inc. | $217.30 | 4 | $0 (2024) |
| Kala Pharmaceuticals, Inc. | $124.80 | 1 | $0 (2019) |
| Shire North American Group Inc | $122.76 | 1 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $118.40 | 5 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $116.36 | 1 | $0 (2020) |
| Alcon Laboratories Inc | $93.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $322.99 | 12 | Genentech USA, Inc. ($85.21) |
| 2023 | $370.95 | 13 | ABBVIE INC. ($136.42) |
| 2022 | $177.05 | 4 | Alcon Vision LLC ($102.08) |
| 2021 | $67.07 | 4 | Novartis Pharmaceuticals Corporation ($29.10) |
| 2020 | $394.22 | 6 | Novartis Pharmaceuticals Corporation ($121.87) |
| 2019 | $801.59 | 13 | Novartis Pharmaceuticals Corporation ($266.67) |
| 2018 | $476.55 | 7 | Allergan Inc. ($204.33) |
| 2017 | $93.38 | 1 | Alcon Laboratories Inc ($93.38) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: EYE CARE | ||||||
| 09/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/29/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Ophthalmology | ||||||
| 07/11/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/11/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Ophthalmology | ||||||
| 04/02/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: EYE CARE | ||||||
| 03/19/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 02/07/2024 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Ophthalmology | ||||||
| 01/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.76 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/13/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: EYE CARE | ||||||
| 11/16/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: EYE CARE | ||||||
| 10/28/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.37 | General |
| Category: EYE CARE | ||||||
| 09/21/2023 | Astellas Pharma US Inc | — | Food and Beverage | In-kind items and services | $20.98 | General |
| 09/09/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/27/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: EYE CARE | ||||||
| 07/15/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/15/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Ophthalmology | ||||||
| 05/12/2023 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: EYE CARE | ||||||
| 04/23/2023 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $71.04 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/02/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $29.93 | General |
| 02/21/2023 | Coherus Biosciences Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Ophthalmology | ||||||
| 02/09/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $36.71 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,232 | 14,743 | $4.1M | $1.6M |
| 2022 | 17 | 2,781 | 7,044 | $3.2M | $1.3M |
| 2021 | 16 | 2,379 | 5,757 | $2.5M | $1.0M |
| 2020 | 16 | 2,349 | 4,831 | $1.4M | $738,263 |
Total Patients
10,741
Total Services
32,375
Medicare Billing
$4.6M
Procedure Codes
66
All Medicare Procedures & Services
66 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 158 | 1,412 | $2.5M | $966,786 | 39.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 32 | 6,840 | $486,203 | $193,991 | 39.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,026 | 1,753 | $474,186 | $161,235 | 34.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 210 | 1,040 | $258,159 | $100,240 | 38.8% |
| 92134 | Imaging of retina | Office | 2023 | 1,085 | 2,369 | $207,861 | $74,817 | 36.0% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 11 | 224 | $86,303 | $35,622 | 41.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 159 | 314 | $56,340 | $23,083 | 41.0% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 87 | 248 | $39,713 | $17,132 | 43.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 98 | $27,073 | $9,005 | 33.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 77 | 77 | $21,538 | $7,539 | 35.0% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 51 | 54 | $11,670 | $6,660 | 57.1% |
| 92250 | Photography of the retina | Office | 2023 | 125 | 129 | $8,141 | $4,101 | 50.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 18 | 63 | $4,464 | $3,373 | 75.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $7,586 | $3,017 | 39.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 36 | 39 | $3,369 | $2,193 | 65.1% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 31 | 39 | $3,400 | $1,515 | 44.5% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 16 | 17 | $614.37 | $402.33 | 65.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 94 | 1,220 | $2.1M | $859,526 | 40.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 881 | 1,636 | $438,236 | $156,592 | 35.7% |
| 67028 | Injection of drug into eye | Office | 2022 | 188 | 940 | $232,288 | $91,905 | 39.6% |
| 92134 | Imaging of retina | Office | 2022 | 890 | 2,101 | $181,838 | $69,276 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 242 | $44,577 | $17,799 | 39.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2022 | 73 | 194 | $29,445 | $12,962 | 44.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2022 | 84 | 217 | $24,672 | $11,420 | 46.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 100 | $26,599 | $9,802 | 36.9% |
About Dr. Erwin Puente, MD
Dr. Erwin Puente, MD is a Ophthalmology healthcare provider based in Hagerstown, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003105677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erwin Puente, MD has received a total of $2,704 in payments from pharmaceutical and medical device companies, with $322.99 received in 2024. These payments were reported across 60 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,704).
As a Medicare-enrolled provider, Puente has provided services to 10,741 Medicare beneficiaries, totaling 32,375 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 66 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Hagerstown, MD
- Active Since 04/04/2011
- Last Updated 03/10/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1003105677
Products in Payments
- OZURDEX (Drug) $455.45
- LUMIGAN (Drug) $203.29
- BEOVU (Drug) $175.84
- Lucentis (Biological) $132.09
- AcrySof (Device) $126.21
- INVELTYS (Drug) $124.80
- XIIDRA (Drug) $122.76
- BROLUCIZUMAB (Drug) $120.25
- ReSTOR (Device) $119.76
- rhopressa (Drug) $116.36
- Clareon (Device) $102.08
- EYLEA HD (Biological) $93.21
- YUTIQ (Drug) $87.88
- Vabysmo (Drug) $85.21
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $71.04
- Cimerli (Biological) $65.49
- Izervay (Drug) $59.93
- Humira (Biological) $37.36
- Tecnis Symfony IOL (Device) $34.21
- Tecnis Multifocal Family of 1-piece IOLS (Device) $30.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Hagerstown
Dr. Robert Parnes, Md, MD
Ophthalmology — Payments: $233,725
Ophthalmology $233,725
David Warrow, M.d, M.D
Ophthalmology — Payments: $79,434
Ophthalmology $79,434
Dr. Augustus Stern, M.d, M.D
Ophthalmology — Payments: $7,520
Ophthalmology $7,520
Kinga Huzella, M.d, M.D
Ophthalmology — Payments: $5,779
Ophthalmology $5,779
Dr. Adam Wenick, Md, Phd, MD, PHD
Ophthalmology — Payments: $5,101
Ophthalmology $5,101
Dr. John Wroblewski, Md, MD
Ophthalmology — Payments: $3,433
Ophthalmology $3,433